Cancer clinical trials in the region Nouvelle-Aquitaine
178 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lung cancer
#NCT06074588
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
ALK
BRAF
EGFR
MET
NTRK-1/2/3
RET
ROS-1
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
9 main criterias to confirm
Institut Bergonié (Bordeaux)
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT04120701
Adenocarcinoma
Localized
Locally Advanced
Systemic Treatment-Naive
Surgery
Systemic Treatment-Naive
Surgery
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
10 main criterias to confirm
Hôpital Privé Francheville (Périgueux), Centre Hospitalier Universitaire Dupuytren (Limoges), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Clinique Tivoli Ducos (Bordeaux), Institut Bergonié (Bordeaux) (and 13 more...)
CHU Dijon
Phase 3
Lymphoma
#NCT05444712
T cell lymphoma
Peripheral T cell lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Systemic Treatment-Naive
9 main criterias to confirm
Polyclinique Bordeaux Nord Aquitaine (Bordeaux)
Hospices Civils de Lyon
Phase 3
Lung cancer
#NCT06311721
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Metastatic
Systemic Treatment-Naive
ALK
EGFR
ROS-1
Immunotherapy
Chemotherapy
Targeted therapy
10 main criterias to confirm
Groupe Hospitalier Saint André (Bordeaux)
Amgen
Phase 3
Lung cancer
#NCT06430866
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Localized
Locally Advanced
Surgery
Chemotherapy
Surgery
Chemotherapy
EGFR
ALK
ROS-1
Immunotherapy
Immunotherapy
12 main criterias to confirm
Centre Hospitalier Universitaire de Bordeaux (Bordeaux)
Amgen
Phase 3
Lung cancer
#NCT06203210
SCLC (Small Cell Lung Cancer)
Chemotherapy
Chemotherapy
6 main criterias to confirm
Centre Hospitalier Universitaire Dupuytren (Limoges)
Daiichi Sankyo
Phase 3
Colon cancer
Rectal cancer
#NCT05078047
Adenocarcinoma
Metastatic
MSI/dMMR
Immunotherapy
7 main criterias to confirm
Clinique Chénieux (Limoges), Groupe Hospitalier Saint André (Bordeaux), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Jean Perrin (Clermont Ferrand ), IUCT Oncopôle (Toulouse) (and 1 more...)
UNICANCER
Phase 3
Pancreas cancer
#NCT00268411
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
8 main criterias to confirm
Clinique Des 4 Pavillons (Lormont), Groupe Hospitalier La Rochelle-Ré-Aunis (La Rochelle), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 3
Colon cancer
Rectal cancer
#NCT05253651
Adenocarcinoma
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
KRAS G12C
KRAS non G12C
NRAS
8 main criterias to confirm
CHU - Haut-Lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Seagen
Phase 3
Lung cancer
#NCT06312137
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
ALK
8 main criterias to confirm
Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Jean Perrin (Clermont Ferrand ), Hôpital Larrey (Toulouse )
Merck Sharp & Dohme LLC